TRUSTEES OF BOSTON UNIVERSITY v. EVERLIGHT ELECTRONICS CO.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Prost, Moore, and Reyna. Appeal from the United States District Court for the District of Massachusetts
Summary: A patent claim having multiple permutations is only enabled if each and every permutation is enabled.
Boston University (“BU”) sued Everlight and others for allegedly infringing a BU patent. The patent related to the preparation of certain films used to make blue LEDs. The court construed the claim at issue to encompass six permutations for how various layers could be formed. Defendants argued the claim was not enabled because the specification did not adequately teach one permutation. The jury found the patent valid and infringed and the District Court denied Defendants’ motion for judgment as a matter of law. Defendants appealed.
The Federal Circuit reversed and held the claim at issue was invalid for lack of enablement. The Federal Circuit acknowledged the parties’ agreement that five of the six claim permutations were enabled and that the specification need not “expressly spell out every possible iteration of every claim.” However, the Federal Circuit held that, “[t]o be enabling, the specification… must teach those skilled in the art how to make and use the full scope of the claimed invention without ‘undue experimentation.’” The Federal Circuit found that the sixth permutation was either impossible or would have required undue experimentation. Thus, the Federal Circuit held the claim was invalid for lack of enablement because enabling five out of six permutations was not sufficient.
This case is: TRUSTEES OF BOSTON UNIVERSITY v. EVERLIGHT ELECTRONICS CO.
Edited by: Paul Stewart
Written by: David C. Kellogg and Adam Powell
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…